Arvinas (ARVN) Interest & Investment Income (2017 - 2026)

Arvinas (ARVN) recorded quarterly Interest & Investment Income of $6.4 million in Q1 2026, down 13.51% quarter-over-quarter from $7.4 million in Q4 2025, and down 45.3% on a YoY basis from $11.7 million in Q1 2025.

Arvinas (ARVN) Interest & Investment Income (2017 - 2026) Analysis & Trends

Arvinas' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $6.4 million for Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 45.3% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $33.1 million (down 36.95% YoY), while the FY2025 annual figure was $38.4 million, down 29.93% from the prior year.
  • Interest & Investment Income was $6.4 million for Q1 2026 at Arvinas, down from $7.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $14.3 million in Q3 2024 to a low of $1.2 million in Q1 2022.
  • Historically, Interest & Investment Income has averaged $8.9 million across 5 years, with a median of $9.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Interest & Investment Income soared 822.55% in 2022, then tumbled 45.3% in 2026.
  • A 5-year view of Interest & Investment Income shows it stood at $5.7 million in 2022, then soared by 114.04% to $12.2 million in 2023, then grew by 5.74% to $12.9 million in 2024, then sank by 42.64% to $7.4 million in 2025, then decreased by 13.51% to $6.4 million in 2026.
  • The last three Interest & Investment Income figures came in at $6.4 million (Q1 2026), $7.4 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 6.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.40 Mn
Dec 31, 2025 7.40 Mn
Sep 30, 2025 9.00 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 11.70 Mn
Dec 31, 2024 12.90 Mn
Sep 30, 2024 14.30 Mn
Jun 30, 2024 13.60 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 12.20 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 9.00 Mn
Mar 31, 2023 7.60 Mn
Dec 31, 2022 5.70 Mn
Sep 30, 2022 3.40 Mn
Jun 30, 2022 1.80 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 620,912.00
Sep 30, 2021 368,545.00
Jun 30, 2021 360,160.00